Hundreds of Alzheimer's patients will get ADHD and diabetes drugs in a trial backed by the grieving Prime Minister

Researchers aim to recruit 1,200 people over four years, against roughly 200 who joined UK Alzheimer's trials in all of 2025-26. Andy Burnham's father Roy, a former telephone engineer, died with the disease in September aged 86 and never knew his son had become PM. The Ad-Smart study tests atomoxetine and metformin side by side, and experts expect it to more than halve testing time.
Chief investigator Professor Paresh Malhotra: 'We just are not testing the most promising treatments quickly enough.'
Experts compared old single-drug trials to building a football stadium for one match.
Burnham said he has made dementia research a national priority and wants Britain leading the breakthroughs.
